186 related articles for article (PubMed ID: 20028875)
41. Molecular biology: damage control.
Azzalin CM; Lingner J
Nature; 2007 Aug; 448(7157):1001-2. PubMed ID: 17728746
[No Abstract] [Full Text] [Related]
42. Telomere attrition induces a DNA double-strand break damage signal that reactivates p53 transcription in HTLV-I leukemic cells.
Datta A; Nicot C
Oncogene; 2008 Feb; 27(8):1135-41. PubMed ID: 17704807
[TBL] [Abstract][Full Text] [Related]
43. Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically.
Subhawong AP; Subhawong T; Nassar H; Kouprina N; Begum S; Vang R; Westra WH; Argani P
Am J Surg Pathol; 2009 Feb; 33(2):163-75. PubMed ID: 18936692
[TBL] [Abstract][Full Text] [Related]
44. Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis.
Zhu Z; Jiang W; Thompson HJ
Mol Carcinog; 1999 Apr; 24(4):241-5. PubMed ID: 10326860
[TBL] [Abstract][Full Text] [Related]
45. Using DNA damage responses to prevent and treat skin cancers.
Gilchrest BA
J Dermatol; 2004 Nov; 31(11):862-77. PubMed ID: 15729858
[No Abstract] [Full Text] [Related]
46. ATM mediates pRB function to control DNMT1 protein stability and DNA methylation.
Shamma A; Suzuki M; Hayashi N; Kobayashi M; Sasaki N; Nishiuchi T; Doki Y; Okamoto T; Kohno S; Muranaka H; Kitajima S; Yamamoto K; Takahashi C
Mol Cell Biol; 2013 Aug; 33(16):3113-24. PubMed ID: 23754744
[TBL] [Abstract][Full Text] [Related]
47. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
48. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
[TBL] [Abstract][Full Text] [Related]
49. ATM gene expression is associated with differentiation and angiogenesis in infiltrating breast carcinomas.
Cuatrecasas M; Santamaria G; Velasco M; Camacho E; Hernandez L; Sanchez M; Orrit C; Murcia C; Cardesa A; Campo E; Fernandez PL
Histol Histopathol; 2006 Feb; 21(2):149-56. PubMed ID: 16329039
[TBL] [Abstract][Full Text] [Related]
50. Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1.
Zahner G; Wolf G; Ayoub M; Reinking R; Panzer U; Shankland SJ; Stahl RA
J Biol Chem; 2002 Mar; 277(12):9763-71. PubMed ID: 11756433
[TBL] [Abstract][Full Text] [Related]
51. ATM mediates cytotoxicity of a mutant telomerase RNA in human cancer cells.
Stohr BA; Blackburn EH
Cancer Res; 2008 Jul; 68(13):5309-17. PubMed ID: 18593932
[TBL] [Abstract][Full Text] [Related]
52. ATM localization and gene expression in the adult mouse eye.
Leemput J; Masson C; Bigot K; Errachid A; Dansault A; Provost A; Gadin S; Aoufouchi S; Menasche M; Abitbol M
Mol Vis; 2009; 15():393-416. PubMed ID: 19234633
[TBL] [Abstract][Full Text] [Related]
53. Cyclooxygenase-2 up-regulates ataxia telangiectasia and Rad3 related through extracellular signal-regulated kinase activation.
Kim YM; Lee EJ; Park SY; Cho KH; Kim JY; Pyo H
Mol Cancer Res; 2009 Jul; 7(7):1158-68. PubMed ID: 19584262
[TBL] [Abstract][Full Text] [Related]
54. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
55. A novel Tel1/ATM N-terminal motif, TAN, is essential for telomere length maintenance and a DNA damage response.
Seidel JJ; Anderson CM; Blackburn EH
Mol Cell Biol; 2008 Sep; 28(18):5736-46. PubMed ID: 18625723
[TBL] [Abstract][Full Text] [Related]
56. Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.
Pereg Y; Shkedy D; de Graaf P; Meulmeester E; Edelson-Averbukh M; Salek M; Biton S; Teunisse AF; Lehmann WD; Jochemsen AG; Shiloh Y
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5056-61. PubMed ID: 15788536
[TBL] [Abstract][Full Text] [Related]
57. COX-2, p16 and Ki67 expression in DCIS, microinvasive and early invasive breast carcinoma with extensive intraductal component.
Bartova M; Ondrias F; Muy-Kheng T; Kastner M; Singer Ch; Pohlodek K
Bratisl Lek Listy; 2014; 115(7):445-51. PubMed ID: 25077370
[TBL] [Abstract][Full Text] [Related]
58. The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.
Reimann M; Loddenkemper C; Rudolph C; Schildhauer I; Teichmann B; Stein H; Schlegelberger B; Dörken B; Schmitt CA
Blood; 2007 Oct; 110(8):2996-3004. PubMed ID: 17562874
[TBL] [Abstract][Full Text] [Related]
59. Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death.
Tian B; Yang Q; Mao Z
Nat Cell Biol; 2009 Feb; 11(2):211-8. PubMed ID: 19151707
[TBL] [Abstract][Full Text] [Related]
60. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
